Filip Vrbacky
Overview
Explore the profile of Filip Vrbacky including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
105
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Petrova L, Vrbacky F, Lanska M, Zavrelova A, Zak P, Hrochova K
Clin Biochem
. 2018 Oct;
63:161.
PMID: 30340751
No abstract available.
12.
Petrova L, Vrbacky F, Lanska M, Zavrelova A, Zak P, Hrochova K
Clin Biochem
. 2018 Sep;
61:34-39.
PMID: 30176240
Objectives: Molecular screening plays a major role in prognostic categorization and subsequent definition of treatment strategies for acute myeloid leukemia. The possibility of using IDH1/2 mutations as a marker for...
13.
Jaruskova M, Curik N, Hercog R, Polivkova V, Motlova E, Benes V, et al.
J Exp Clin Cancer Res
. 2017 Apr;
36(1):55.
PMID: 28420426
Background: Through high-throughput next-generation sequencing of promoters of solute carrier and ATP-binding cassette genes, which encode drug transporters, we aimed to identify SNPs associated with the response to imatinib administered...
14.
Simkovic M, Motyckova M, Belada D, Vodarek P, Kapoor R, Jaffar H, et al.
Arch Med Sci
. 2016 May;
12(2):421-7.
PMID: 27186190
Introduction: High-dose methylprednisolone (HDMP) in combination with rituximab is active in the treatment of relapsed/refractory chronic lymphocytic leukemia (CLL), but serious infections are frequent. Recently published data suggested that high-dose...
15.
Plesingerova H, Librova Z, Plevova K, Libra A, Tichy B, Skuhrova Francova H, et al.
Leuk Lymphoma
. 2016 May;
58(1):70-79.
PMID: 27185377
The clinical course of chronic lymphocytic leukemia (CLL) is highly variable. Patients with unmutated IGHV (U-CLL) usually progress rapidly, whereas patients with mutated IGHV (M-CLL) have a more indolent disease....
16.
Kacerovsky M, Vrbacky F, Kutova R, Pliskova L, Andrys C, Musilova I, et al.
PLoS One
. 2015 May;
10(5):e0126884.
PMID: 25993616
Objective: To analyze the cervical microbiota in women with preterm prelabor rupture of membranes (PPROM) by pyrosequencing and to document associations between cervical microbiota, cervical inflammatory response, microbial invasion of...
17.
Kostal M, Zak P, Vejrazkova E, Cermanova M, Belohlavkova P, Zavrelova A, et al.
Acta Medica (Hradec Kralove)
. 2013 Jan;
55(3):142-5.
PMID: 23297524
No abstract available.
18.
Vroblova V, Vrbacky F, Hrudkova M, Jankovicova K, Schmitzova D, Maly J, et al.
Eur J Haematol
. 2010 Feb;
84(6):513-7.
PMID: 20132303
Introduction: It is widely accepted that expression of ZAP-70 in chronic lymphocytic leukemia (CLL) remains stable in time. However, data supporting this notion are surprisingly scarce. Therefore, we assessed expression...
19.
Vroblova V, Smolej L, Vrbacky F, Jankovicova K, Hrudkova M, Maly J, et al.
Acta Medica (Hradec Kralove)
. 2009 Sep;
52(1):3-8.
PMID: 19754000
Chronic lymphocytic leukemia (CLL) is the most frequent leukemic disease of adults in the Western world. It is remarkable by an extraordinary heterogeneity of clinical course with overall survival ranging...